Cannapharmarx (CPMD) Stock Statistics & Valuation Metrics

Cannapharmarx has a market cap or net worth of $2.65M. The enterprise value is $48.56M.

Cannapharmarx has 662,501,400 shares outstanding. The number of shares has decreased by -2.65% in one year.

Cannapharmarx’s return on equity (ROE) is 0.50 and return on invested capital (ROIC) is 55.67%.

The current PE Ratio of Cannapharmarx is -0.51. Cannapharmarx’s PEG ratio is >-0.01.

In the last 12 months, Cannapharmarx had revenue of 820.14K and earned -9.91M in profits. Earnings per share was -0.02.

In the last 12 months, operating cash flow was -1.70M and capital expenditures -4.00, giving a free cash flow of -1.70M billion.

Cannapharmarx pays an annual dividend of ―, resulting in a dividend yield of ―

Cannapharmarx upcoming earnings date is May 20, 2025, TBA Not Confirmed.

Cannapharmarx as a current ratio of 0.04, with Debt / Equity ratio of 191.22%

In the past 12 months, Cannapharmarx has paid 0.00 in taxes.

Cannapharmarx EV to EBITDA ratio is -2.50, with an EV/FCF ratio of -11.27.

Cannapharmarx has $2.16K in cash and marketable securities with $14.06M in debt, giving a net cash position of $14.06M billion.

Gross margin is 0.00%, with operating margin of -439.71%, and net profit margin of -1207.82%.

The average price target for Cannapharmarx is ―, which is 11.43% higher than the current price. The consensus rating is ―